Search
for
Sort by
Research 841–870 of 1000+
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Metformin or Antiandrogen in the Treatment of Hirsutism in Polycystic Ovary Syndrome
- Effects of Sex Steroid Deprivation/Administration on Hair Growth and Skin Sebum Production in Transsexual Males and Females
- Clinical and Hormonal Effects of Chronic Gonadotropin Releasing Hormone Agonist Treatment in Polycystic Ovarian Disease*
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- Dihydrotestosterone Stimulates 5a-Reductase Activity in Pubic Skin Fibroblasts*
- A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
- Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*
- Estimating the Contribution of the Prostate to Blood Dihydrotestosterone
- A Perspective on the Evolving Landscape in Male Reproductive Medicine
- Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men.
- Presence of hyperandrogenemia in cases evaluated due to menstrual irregularity, the effect of clinical and/or biochemical hyperandrogenemia on polycystic ovary syndrome
- Response to Letter: “Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss”
- A Novel Use of Spironolactone: Treatment of Hirsutism
- Gonadotropin-Releasing Hormone Agonist Treatment in Postmenopausal Women with Hyperandrogenism of Ovarian Origin
- A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain1
- A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain
- A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia among Women Presenting with Hyperandrogenic Symptoms and Signs
- Treatment of Hirsutism with a Gonadotropin-Releasing Hormone Agonist (Nafarelin)∗
- Treatment of hirsutism and acne in hyperandrogenism
- Markers of hyperandrogenism in South Asians with polycystic ovary syndrome
- Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women
- An adolescent girl with coexisting ovarian mature cystic teratoma and HAIR-AN syndrome, an extreme subtype of polycystic ovarian syndrome
- Sex hormones and sarcopenia in older persons
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Aldosterone- and cortisol-cosecreting adrenal adenoma, ovarian hyperthecosis and breast cancer
- A benign cause of hyperandrogenism in a postmenopausal woman
- Hyperandrogenism and Polycystic Ovary Syndrome in Women with Type 1 Diabetes Mellitus
- Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
- Nonclassic congenital adrenal hyperplasia and the heterozygote carrier